• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ciprofloxacin therapy in cystic fibrosis.

作者信息

Raeburn J A, Govan J R, McCrae W M, Greening A P, Collier P S, Hodson M E, Goodchild M C

机构信息

University of Edinburgh.

出版信息

J Antimicrob Chemother. 1987 Sep;20(3):295-6. doi: 10.1093/jac/20.3.295.

DOI:10.1093/jac/20.3.295
PMID:3680073
Abstract
摘要

相似文献

1
Ciprofloxacin therapy in cystic fibrosis.环丙沙星在囊性纤维化治疗中的应用
J Antimicrob Chemother. 1987 Sep;20(3):295-6. doi: 10.1093/jac/20.3.295.
2
Ciprofloxacin in cystic fibrosis.环丙沙星与囊性纤维化
Lancet. 1986 May 10;1(8489):1103. doi: 10.1016/s0140-6736(86)91374-7.
3
Ciprofloxacin in the treatment of Pseudomonas infection in children with cystic fibrosis.环丙沙星治疗囊性纤维化患儿的铜绿假单胞菌感染
Diagn Microbiol Infect Dis. 1990 Mar-Apr;13(2):153-5. doi: 10.1016/0732-8893(90)90099-h.
4
Quality of well-being before and after antibiotic treatment of pulmonary exacerbation in patients with cystic fibrosis.囊性纤维化患者肺部加重期抗生素治疗前后的健康状况质量
Chest. 1990 Nov;98(5):1081-4. doi: 10.1378/chest.98.5.1081.
5
Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.环丙沙星用于上呼吸道感染以减少儿童囊性纤维化患者铜绿假单胞菌感染：一项试点研究。
Ther Adv Respir Dis. 2015 Dec;9(6):272-80. doi: 10.1177/1753465815601571. Epub 2015 Sep 4.
6
[Ciprofloxacin: an alternative oral treatment in respiratory Pseudomonas infection in cystic fibrosis].环丙沙星：囊性纤维化患者呼吸道铜绿假单胞菌感染的一种口服替代治疗方法
Pediatr Med Chir. 1990 Sep-Oct;12(5):531-4.
7
Cystic fibrosis: intravenous treatment at home.囊性纤维化：在家进行静脉治疗。
Nurs Times. 1989;85(12):40-2.
8
Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis.阿洛西林用于囊性纤维化患儿铜绿假单胞菌所致的呼吸道感染
Chemotherapy. 1980;26(2):135-40. doi: 10.1159/000237895.
9
Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.亚优化环丙沙星剂量可能导致囊性纤维化患儿铜绿假单胞菌敏感性降低。
Pharmacotherapy. 2010 Dec;30(12):1252-8. doi: 10.1592/phco.30.12.1252.
10
[Making antibiotic therapy easier to use. A welcome advance for those with cystic fibrosis].[使抗生素治疗更易于使用。对囊性纤维化患者来说是一项值得欢迎的进展]
Perspect Infirm. 2011 Jul-Aug;8(4):54-5.

引用本文的文献

1
Cystic fibrosis--an Indian perspective on recent advances in diagnosis and management.囊性纤维化——印度对诊断与管理最新进展的观点
Indian J Pediatr. 1996 Mar-Apr;63(2):189-98. doi: 10.1007/BF02845243.
2
Safety and efficacy of ciprofloxacin in paediatric patients--review.环丙沙星在儿科患者中的安全性和有效性——综述
Infection. 1993 Nov-Dec;21(6):413-21. doi: 10.1007/BF01728929.
3
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.环丙沙星：抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1988 Apr;35(4):373-447. doi: 10.2165/00003495-198835040-00003.
4
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
5
Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study.中性粒细胞减少儿童预防性使用复方新诺明与诺氟沙星的前瞻性随机研究
Infection. 1989 Mar-Apr;17(2):65-9. doi: 10.1007/BF01646878.
6
Isolation of fluoroquinolone-resistant Escherichia coli and Klebsiella pneumoniae from an infected Hickman catheter.从一根受感染的希克曼导管中分离出耐氟喹诺酮的大肠杆菌和肺炎克雷伯菌。
Eur J Clin Microbiol Infect Dis. 1990 May;9(5):345-7. doi: 10.1007/BF01973741.
7
Development of resistance to ciprofloxacin in nutrient-rich and nutrient-limited growth conditions in vitro by Pseudomonas aeruginosa isolates from patients with cystic fibrosis.囊性纤维化患者分离出的铜绿假单胞菌在富含营养和营养受限的体外生长条件下对环丙沙星耐药性的发展
Antimicrob Agents Chemother. 1991 Dec;35(12):2649-51. doi: 10.1128/AAC.35.12.2649.
8
In vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patients.新型喹诺酮类药物司帕沙星（AT - 4140）对儿科患者侵袭性分离株的体外活性
Antimicrob Agents Chemother. 1992 Feb;36(2):255-61. doi: 10.1128/AAC.36.2.255.